Latest news
RiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 07:28:07 GMTBlue Cell Therapeutics shuts in vivo unit ahead of clinical trial: Staff laid off - medwatch.commedwatch.com · Fri, 07 Aug 2026 12:06:35 GMTHow AI is transforming in vivo research - News-MedicalNews-Medical · Fri, 07 Aug 2026 08:57:00 GMTIntellia Prepares for Anticipated 2027 Commercial Launch of First In Vivo Gene Editor - Precision Medicine OnlinePrecision Medicine Online · Thu, 06 Aug 2026 19:23:40 GMTA suite of engineered mice for interrogating psychedelic drug actions - NatureNature · Thu, 06 Aug 2026 10:40:34 GMTCRISPR: "Strong Buy" CASGEVY Sales Growth And In Vivo Expansion With CTX310 (NASDAQ:CRSP) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 14:09:04 GMTEngineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice - NatureNature · Wed, 05 Aug 2026 10:48:30 GMTRSV Drug Discovery Models: In Vitro and In Vivo Evaluation of Presatovir - EvotecEvotec · Tue, 04 Aug 2026 08:24:04 GMT